0001628280-22-029839.txt : 20221215 0001628280-22-029839.hdr.sgml : 20221215 20221114161603 ACCESSION NUMBER: 0001628280-22-029839 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20221114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Context Therapeutics Inc. CENTRAL INDEX KEY: 0001842952 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 863738787 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 2001 MARKET STREET STREET 2: SUITE 3915 UNIT #15 CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 267-225-7416 MAIL ADDRESS: STREET 1: 2001 MARKET STREET STREET 2: SUITE 3915 UNIT #15 CITY: PHILADELPHIA STATE: PA ZIP: 19103 FORMER COMPANY: FORMER CONFORMED NAME: Context Therapeutics LLC DATE OF NAME CHANGE: 20210128 CORRESP 1 filename1.htm Document

Context Therapeutics Inc.
2001 Market Street, Suite 3915, Unit #15
Philadelphia, Pennsylvania 19103
November 14, 2022
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
 
 Re:
Context Therapeutics Inc.
Registration Statement on Form S-3
File No. 333-268266
Ladies and Gentlemen:
Pursuant to Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, on behalf of Context Therapeutics Inc., respectfully requests that the effective date of the Registration Statement on Form S-3 referred to above be accelerated so that it will become effective at 4:00 P.M. Eastern Time on November 16, 2022, or as soon as practicable thereafter.
If you have any questions or require additional information, please contact Walter J. Mostek, Esq. of Faegre Drinker Biddle & Reath LLP at (215) 988-3330. Thank you for your assistance and cooperation in this matter.
 
Very truly yours,
CONTEXT THERAPEUTICS INC.

By: /s/ Martin Lehr
 
Martin Lehr
Chief Executive Officer
 
 
cc:
Jennifer Minai-Azary, Chief Financial Officer, Context Therapeutics Inc.
Alex Levit, Chief Legal Officer, Context Therapeutics Inc.
Walter J. Mostek, Esq., Faegre Drinker Biddle & Reath LLP